BioWorld MedTech briefs for December 24, 2024.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Applied, Astrazeneca, Bristol Myers, Eli Lilly, Glaukos, Keymed, Novo Nordisk, Nuvation, Pfizer, Rhythm, Tonix, Vertex.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Corxel, Ikena, Inmagene, Jemincare, Neurosense, Rapt, Vicentage.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bristol Myers Squibb, Traws, Vyne, Xbiotech.

Biopharmas raising money in public or private financings, including: Anebulo, Cadrenal, Psyence, Rapt, TME Pharma.

Med-tech firms raising money in public or private financings, including: Merck, Personalis.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 10x, Allurion, Avero, Bruker, Fuse-AI, Personalis, Pineapple Power, Prescient Medical, Merck, Moderna, Myr, Northwest Pathology, Signati, Solvd, Spectral AI, Statlab, Trinity Biotech, Versant, Vivos, Xlife.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Avita.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Accord, Celltrion, CSL Berhing, Everest, Eli Lilly, Innovent, Mesoblast, Merck.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ena Respiratory, Immunabs, Immutep, Microbio.